Decreasing arm morbidity by refining axillary surgery in breast cancer

European Journal of Surgical Oncology

Volumn 35, Issue 4, 2009, Pages 335-338

  Ponzone, R ^a   Cassina, E ^a   Tomasi Cont, N ^a   Biglia, N ^a   Sismondi, P ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Axillary; Breast; Cancer; Dissection; Intercostobrachial; Sentinel

Indexed keywords

AXILLARY LYMPH NODE; BRACHIAL PLEXUS; BREAST CANCER; CANCER SURGERY; DISEASE ASSOCIATION; EDITORIAL; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHATIC DRAINAGE; MORBIDITY; PRIORITY JOURNAL; QUALITY OF LIFE; SENTINEL LYMPH NODE BIOPSY; SURGICAL TECHNIQUE;

ARM; AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; INTERCOSTAL NERVES; LYMPH NODE EXCISION; MIDDLE AGED; SENTINEL LYMPH NODE BIOPSY; SENTINEL SURVEILLANCE;

EID: 60849133982     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2008.06.1494     Document Type: Editorial

References (41)

1. Halsted W.S. The results of operations for the cure of cancer of the breast performed at the Johns Hopkins Hospital from June 1889 to January 1894. Johns Hopkins Hosp Bull 4 (1894) 297-323
2. Fisher B., Anderson S., Bryant J., et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347 (2002) 1233-1241
3. Veronesi U., Cascinelli N., Mariani L., et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347 (2002) 1227-1232
4. Maddox W.A., Carpenter Jr. J.T., Laws H.L., et al. A randomized prospective trial of radical (Halsted) mastectomy versus modified radical mastectomy in 311 breast cancer patients. Ann Surg 98 (1983) 207-212
5. Veronesi U., Marubini E., Mariani L., Valagussa P., and Zucali R. The dissection of internal mammary nodes does not improve the survival of breast cancer patients. 30-year results of a randomised trial. Eur J Cancer 35 (1999) 1320-1325
6. Fisher B. Seminars of Bernard Fisher 1960 - nature of cancer as systemic disease?. Bull Soc Int Chir 31 (1972) 604-609
7. Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365 (2005) 1687-1717
8. Giuliano A.E., Kirgan D.M., Guenther J.M., and Morton D.L. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 3 (1994) 391-401
9. Mansel R.E., Fallowfield L., Kissin M., et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst 98 (2006) 599-609
10. Bergkvist L., de Boniface J., Jönsson P.E., et al. Swedish Axillary recurrence rate after negative sentinel node biopsy in breast cancer: three-year follow-up of the Swedish Multicenter Cohort Study. Society of Breast Surgeons. Ann Surg 247 (2008) 150-156
11. Naik A.M., Fey J., Gemignani M., et al. The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection. A follow-up study of 4008 procedures. Ann Surg 240 (2004) 462-471
12. Krag D.N., Anderson S.J., Julian T.B., et al. National Surgical Adjuvant Breast and Bowel Project Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol 8 (2007) 881-888
13. Ponzone R., Maggiorotto F., Mariani L., et al. Comparison of two models for the prediction of nonsentinel node metastases in breast cancer. Am J Surg 193 (2007) 686-692
14. Berg J.W. The significance of axillary node levels in the study of breast carcinoma. Cancer 8 (1955) 776-778
15. NIH Consensus Conference. Treatment of early-stage breast cancer. JAMA 265 (1991) 391-395
16. Ung O., Tan M., Chua B., and Barraclough B. Complete axillary dissection: a technique that still has relevance in contemporary management of breast cancer. ANZ J Surg 76 (2006) 518-521
17. Trost O., Danino A., Benoît L., et al. Lymph node clearance: is surgical practice homogenous?. Ann Chir Plast Esthet 52 (2007) 555-558
18. Kutiyanawala M.A., Stotter A., and Windle R. Anatomical variants during axillary dissection. Br J Surg 85 (1998) 393-394
19. Tan M.P., and Ung O.A. Surgical approach to the angular vein of the axilla: an "inverted" technique of axillary dissection. Breast J 13 (2007) 220-222
20. Nandipati K.C., Raina R., Agarwal A., and Zippe C.D. Nerve-sparing surgery significantly affects long-term continence after radical prostatectomy. Urology 70 (2007) 1127-1130
21. Fujii S., Takakura K., Matsumura N., et al. Anatomic identification and functional outcomes of the nerve sparing Okabayashi radical hysterectomy. Gynecol Oncol 107 (2007) 4-13
22. Assa J. The intercostobrachial nerve in radical mastectomy. J Surg Oncol 6 (1974) 123-126
23. Teicher I., Poulard B., and Wise L. Preservation of the intercostobrachial nerve during axillary dissection for carcinoma of the breast. Surg Gynecol Obstet 155 (1982) 891-892
24. Temple W.J., and Ketcham A.S. Preservation of the intercostobrachial nerve during axillary dissection for breast cancer. Am J Surg 150 (1985) 585-588
25. Maycock L.A., Dillon P., and Dixon J.M. Morbidity related to intercostobrachial nerve damage following axillary surgery for breast cancer. Breast 7 (1998) 209-212
26. Salmon R.J., Ansquer Y., and Asselain B. Preservation versus section of intercostal-brachial nerve (IBN) in axillary dissection for breast cancer - a prospective randomized trial. Eur J Surg Oncol 24 (1998) 158-161
27. Abdullah T.I., Iddon J., Barr L., Baildam A.D., and Bundred N.J. Prospective randomised controlled trial of preservation of the intercostobrachial nerve during axillary node clearance for breast cancer. Br J Surg 85 (1998) 1443-1445
28. Torresan R.Z., Cabello C., Conde D.M., and Brenelli H.B. Impact of the preservation of the intercostobrachial nerve in axillary lymphadenectomy due to breast cancer. Breast J 9 (2003) 389-392
29. Freeman S.R., Washington S.J., Pritchard T., Barr L., Baildam A.D., and Bundred N.J. Long term results of a randomised prospective study of preservation of the intercostobrachial nerve. Eur J Surg Oncol 29 (2003) 213-215
30. Cunnick G.H., Upponi S., and Wishart G.C. Anatomical variants of the intercostobrachial nerve encountered during axillary dissection. Breast 10 (2001) 160-162
31. Loukas M., Louis Jr. R.G., and Wartmann C.T. T2 contributions to the brachial plexus. Neurosurgery 60 2 Suppl. 1 (2007) 13-18
32. Loukas M., Louis R.G., Fogg Q.A., et al. An unusual innervation of pectoralis minor and major muscles from a branch of the intercostobrachial nerve. Clin Anat 19 (2006) 347-349
33. Thompson M., Korourian S., Henry-Tillman R., et al. Axillary reverse mapping (ARM): a new concept to identify and enhance lymphatic preservation. Ann Surg Oncol 14 (2007) 1890-1895
34. Nos C., Lesieur B., Clough K.B., and Lecuru F. Blue dye injection in the arm in order to conserve the lymphatic drainage of the arm in breast cancer patients requiring an axillary dissection. Ann Surg Oncol 14 9 (2007) 2490-2496
35. Sakorafasa G.H., Perosa G., Cataliotti L., et al. Lymphedema following axillary lymph node dissection for breast cancer. Surg Oncol 15 (2006) 153-165
36. Ponzone R., Mininanni P., Cassina E., and Sismondi P. Axillary reverse mapping in breast cancer: can we spare what we find?. Ann Surg Oncol 15 (2008) 390-391
37. Nos C., Lesieur B., Clough K.B., Collignon M.A., and Lecuru F. Comments to the letter to the editor by Dr. Ponzone. Ann Surg Oncol 15 (2008) 392-393
38. Boneti C., Korourian S., Bland K., et al. Axillary reverse mapping: mapping and preserving arm lymphatics may be important in preventing lymphedema during sentinel lymph node biopsy. J Am Coll Surg 206 (2008) 1038-1042
39. Clarke M., Collins R., Darby S., et al., Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366 (2005) 2087-2106
40. Punglia R.S., Morrow M., Winer E.P., and Harris J.R. Local therapy and survival in breast cancer. N Engl J Med 356 (2007) 2399-2405
41. Nattinger A.B., Hoffmann R.G., Kneusel R.T., and Schapira M.M. Relation between appropriateness of primary therapy for early-stage breast carcinoma and increased use of breast-conserving surgery. Lancet 356 (2000) 1148-1153